1. 1) Frishman WH, Grewall P. Serotonin and the heart. Ann. Med., 32, 195–209 (2000).
2. 2) Villalón CM, Heiligers JP, Centurión D, De Vries P, Saxena PR. Characterization of putative 5-HT7 receptors mediating tachycardia in the cat. Br. J. Pharmacol., 121, 1187–1195 (1997).
3. 3) Brogden RN, Sorkin EM. Ketanserin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in hypertension and peripheral vascular disease. Drugs, 40, 903–949 (1990).
4. 4) Grover GJ, Sargent CA, Dzwonczyk S, Normandin DE, Antonaccio MJ. Protective effect of serotonin (5-HT2) receptor antagonists in ischemic rat hearts. J. Cardiovasc. Pharmacol., 22, 664–672 (1993).
5. 5) Grover GJ, Parham CS, Youssef S, Ogletree ML. Protective effect of the serotonin receptor antagonist cinanserin in two canine models of pacing-induced myocardial ischemia. Pharmacology, 50, 286–297 (1995).